Can you provide the last earnings date for KYMERA THERAPEUTICS INC?
KYMERA THERAPEUTICS INC (KYMR) last reported earnings on 2/26/2026.
NASDAQ:KYMR • US5015751044
Past quarterly earnings results for KYMERA THERAPEUTICS INC (KYMR), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | -0.97 | -0.81 | -19.43% | -10.23% | 2.871M | 15.349M | -81.30% | -61.17% |
| Q3 2025 | -0.94 | -0.82 | -14.63% | -14.63% | 2.764M | 19.331M | -85.70% | -26.12% |
| Q2 2025 | -0.95 | -0.83 | -14.98% | -63.79% | 11.476M | 23.855M | -51.89% | -55.26% |
| Q1 2025 | -0.82 | -0.93 | 12.26% | -32.26% | 22.1M | 10.358M | 113.36% | 114.83% |
| Q4 2024 | -0.88 | -0.79 | -11.39% | -252.00% | 7.394M | 12.056M | -38.67% | -84.56% |
| Q3 2024 | -0.82 | -0.86 | 4.15% | 8.89% | 3.741M | 10.567M | -64.60% | -20.88% |
| Q2 2024 | -0.58 | -0.70 | 16.79% | 13.43% | 25.65M | 12.805M | 100.31% | 55.33% |
| Q1 2024 | -0.62 | -0.74 | 16.38% | 11.43% | 10.287M | 13.961M | -26.32% | 8.67% |
| Q4 2023 | -0.25 | -0.41 | 39.48% | 58.33% | 47.884M | 42.801M | 11.88% | 196.68% |
| Q3 2023 | -0.90 | -0.65 | -37.58% | -13.92% | 4.728M | 16.292M | -70.98% | -50.49% |
| Q2 2023 | -0.67 | -0.65 | -3.17% | 14.10% | 16.513M | 14.339M | 15.16% | 43.47% |
| Q1 2023 | -0.70 | -0.69 | -1.30% | 1.41% | 9.466M | 14.437M | -34.43% | -1.60% |
| Q4 2022 | -0.60 | -0.65 | 7.09% | 9.09% | 16.14M | 22.012M | -26.68% | 5.63% |
| Q3 2022 | -0.79 | -0.73 | -7.82% | -41.07% | 9.55M | 15.823M | -39.64% | -53.05% |
| Q2 2022 | -0.78 | -0.70 | -10.73% | -41.82% | 11.51M | 14.522M | -20.74% | -37.85% |
| Q1 2022 | -0.71 | -0.68 | -5.13% | -144.83% | 9.62M | 16.56M | -41.91% | -48.56% |
| Q4 2021 | -0.66 | -0.48 | -38.75% | -127.59% | 15.28M | 21.739M | -29.71% | 19.47% |
| Q3 2021 | -0.56 | -0.37 | -49.37% | -43.59% | 20.34M | 20.003M | 1.68% | 39.99% |
| Q2 2021 | -0.55 | -0.26 | -108.19% | - | 18.52M | 19.191M | -3.50% | 175.76% |
| Q1 2021 | -0.29 | -0.15 | -91.88% | - | 18.7M | 19.433M | -3.77% | - |
| Q4 2020 | -0.29 | -0.05 | -450.25% | - | 12.79M | 22.032M | -41.95% | - |
| Q3 2020 | -0.39 | -0.21 | -82.07% | - | 14.53M | 18.36M | -20.86% | - |
| Q2 2020 | - | - | 6.716M | - | - |
Notes
KYMERA THERAPEUTICS INC (KYMR) last reported earnings on 2/26/2026.
KYMERA THERAPEUTICS INC (KYMR) missed EPS estimates and missed revenue estimates in the most recent quarter.
In the last 4 quarters, KYMERA THERAPEUTICS INC (KYMR) has beaten EPS estimates in 1 out of 4 releases.